TYPHIM Vi, solution for injection in a pre-filled syringe. vaccine typhoid polysaccharide syringe, 0.5 ml, CIP 3400936993020
Active ingredients: POLYOSIDE DE SALMONELLA TYPHI SOUCHE TY2
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionsyringe, 0.5 ml, CIP 3400936993020intramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TYPHIM Vi, solution injectable en seringue préremplie. Vaccin typhoïdique polyosidique
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,5 ml avec deux aiguilles séparées
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 26 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68790394CIP73699302CIP133400936993020Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POLYOSIDE DE SALMONELLA TYPHI SOUCHE TY2solution | 0,025 mg · une dose de 0,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.